Normal substantia nigra patients treated with levodopa - Clinical, therapeutic and pathological observations

Individuals with normal substantia nigra do not benefit from levodopa and do not manifest motor response fluctuations or dyskinesia. Long-term use of levodopa is not toxic to normal human substantia nigra.